Author:
Mayer Theodor K,Vargas Roberto L,Knebel Ann E,Williams Scott A,Culver Sean P,Clark Daniel M,King Louise R
Abstract
Abstract
Background
Screening and determining the immune status of individuals for hepatitis B is usually done by detecting hepatitis B surface antigen (HBsAg) and hepatitis B surface antigen-specific antibodies (HBsAb). In some countries with the highest viral burden, performing these assays is currently impractical. This paper explores the use of filter paper as a blood specimen transport medium.
Methods
Samples, chosen from routine clinical laboratory pool, were applied and dried onto filter paper. Eluates, from the paper samples, were analyzed as routine clinical specimens on ADVIA Centaur 5634® immunoassay analyzers using the standard HBsAg and HBsAb kits. Dried blood samples were subjected to a range of environmental conditions in order to assess stability.
Results
After drying and elution the assays showed linearity and precision comparable to clinical assays performed on fresh serum. Elutions at various times during a 149 day incubation period showed very little variability in the Index numbers. All analytes were temperature stable except for a decrease in the HBsAg signal at 42°C.
Conclusions
Filter paper is an acceptable storage and transport medium for serum to be used in the detection of hepatitis B markers if atmospheric variability can be controlled. HBsAg, HBsAb and HBcAb are all stable for at least five months under storage conditions below room temperature. Drying specimens, particularly serum, on filter paper at remote locations, offers a reasonable solution to the problem of hepatitis surveillance in underdeveloped regions, although some attempt at temperature control might be desirable.
Publisher
Springer Science and Business Media LLC
Subject
Histology,Pathology and Forensic Medicine
Reference21 articles.
1. Williams R: Global challenges in liver disease. Hepatology (Baltimore, Md.). 2006, 44 (3): 521-526. 10.1002/hep.21347.
2. World Health Organization: http://www.who.int/mediacentre/factsheets/fs204/en/(Accessed January 21, 2011)
3. Dienstag JL: Hepatitis B virus infection. N Engl J Med. 2008, 359: 1486-1500. 10.1056/NEJMra0801644.
4. Pungpapong S, Kim W, Poterucha J: Natural History of Hepatitis B Virus Infection: an Update for Clinicians. Mayo Clin Proc. 2007, 82 (8): 967-10.4065/82.8.967.
5. Centers for Disease Control and Prevention: A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part 1: Immunization of Infants, Children, and Adolescents. MMWR Morb Mortal Wkly Rep. 2005, 54 (RR16): 1-23.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献